← Back to Patent Explorer
US4214048A Expired / Lapsed US ⏱️ 0.0 years remaining

Reagent suitable for enzyme immuno assay

Assignee: Sumitomo Pharma Co Ltd
•
Filing: 1978-04-26
•
Granted: 1980-07-22
•
Expires: 1998-04-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel maleimidobenzoic acid N-hydroxysuccinimide ester of the formula: <IMAGE> (I) which is suitable as a binding agent for binding an enzyme and an antigen to give an enzyme-labeled antigen of the formula: <IMAGE> (II) wherein X and Y are different and are each an enzyme or an antigen, and an enzyme immuno assay using the enzyme-labeled antigen (II) and further a kit for the enzyme immuno assay which contains the enzyme-labeled antigen (II).

Inventors

  • 👤 Tsunehiro Kitagawa

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 10:11
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/44; C07D207/444; C07D207/448; C07D207/452; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535; Y; Y10; Y10S; Y10S435/00; Y10S435/961; Y10S435/964; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/808

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 27 words
An enzyme-labeled antigen suitable for an enzyme immuno assay having the following formula: ##STR15## wherein X and Y are different and are each an enzyme or antigen.
Claim 2
Dependent Claim 27 words
An enzyme-labeled antigen suitable for an enzyme immuno assay having the following formula: ##STR15## wherein X and Y are different and are each an enzyme or antigen.
Claim 3
Dependent Claim 25 words
The enzyme-labeled antigen according to claim 1, which has the following formula: ##STR16## wherein X and Y are the same as defined in claim 1.
Claim 4
Dependent Claim 17 words
The enzyme-labeled antigen according to claim 1, wherein X is an antigen and Y is an enzyme.
Claim 5
Dependent Claim 15 words
The enzyme-labeled antigen according to claim 3, wherein X is insulin and Y is β-D-galactosidase.
Claim 6
Dependent Claim 15 words
The enzyme-labeled antigen according to claim 3, wherein X is triiodothyronine and Y is β-D-galactosidase.
Claim 7
Dependent Claim 16 words
The enzyme-labeled antigen according to claim 3, wherein X is angiotensin I and Y is β-D-galactosidase.
Claim 8
Dependent Claim 17 words
The enzyme-labeled antigen according to claim 1, wherein X is an enzyme and Y is an antigen.
Claim 9
Dependent Claim 16 words
The enzyme-labeled antigen according to claim 1, wherein one of X and Y is a hormone.
Claim 10
Dependent Claim 24 words
The enzyme-labeled antigen according to claim 5, wherein the hormone is a member selected from the group consisting of insulin, angiotensin I and iodothyronines.
Claim 11
Dependent Claim 16 words
The enzyme-labeled antigen according to claim 1, wherein one of X and Y is a hapten.
Claim 12
Dependent Claim 12 words
The enzyme-labeled antigen according to claim 10, wherein the hapten is diphenylpropylamine.
Claim 13
Dependent Claim 11 words
The enzyme-labeled antigen according to claim 1, wherein Y is β-D-galactosidase.
Claim 14
Dependent Claim 24 words
The enzyme-labeled antigen according to claim 1, wherein X is a member selected from the group consisting of peroxidase, glucose oxidase and alkaline phosphatase.
Claim 15
Dependent Claim 94 words
In a method for conducting an enzyme immuno assay which comprises subjecting an enzyme-labeled antigen, an unlabeled antigen and an antibody to a competitive antigen-antibody reaction in a buffered solution, separating the enzyme-labeled antigen bound to the antibody from the free labeled antigen, and determining the amount of the unlabeled antigen by measuring an enzyme activity of either the labeled antigen bound to the antibody or the free labeled antigen, the improvement wherein the enzyme-labeled antigen has the following formula: ##STR17## wherein X and Y are different and are each an enzyme or antigen.
Claim 16
Dependent Claim 94 words
In a method for conducting an enzyme immuno assay which comprises subjecting an enzyme-labeled antigen, an unlabeled antigen and an antibody to a competitive antigen-antibody reaction in a buffered solution, separating the enzyme-labeled antigen bound to the antibody from the free labeled antigen, and determining the amount of the unlabeled antigen by measuring an enzyme activity of either the labeled antigen bound to the antibody or the free labeled antigen, the improvement wherein the enzyme-labeled antigen has the following formula: ##STR17## wherein X and Y are different and are each an enzyme or antigen.
Claim 17
Dependent Claim 122 words
A kit for an enzyme immuno assay which comprises subjecting an enzyme-labeled antigen, an unlabeled antigen and an antibody to a competitive antigen-antibody reaction in a buffered solution, separating the enzyme-labeled antigen bound to the antibody from the free labeled antigen, and determining the amount of the unlabeled antigen by measuring an enzyme activity of either the labeled antigen bound to the antibody or the free labeled antigen, said kit containing the following three components as essential components: Component A: an enzyme-labeled antigen of the formula: ##STR18## wherein X and Y are different and are each an enzyme or antigen, Component B: an antibody against the antigen of component A, and Component C: a substrate for the enzyme of the component A.
Claim 18
Dependent Claim 122 words
A kit for an enzyme immuno assay which comprises subjecting an enzyme-labeled antigen, an unlabeled antigen and an antibody to a competitive antigen-antibody reaction in a buffered solution, separating the enzyme-labeled antigen bound to the antibody from the free labeled antigen, and determining the amount of the unlabeled antigen by measuring an enzyme activity of either the labeled antigen bound to the antibody or the free labeled antigen, said kit containing the following three components as essential components: Component A: an enzyme-labeled antigen of the formula: ##STR18## wherein X and Y are different and are each an enzyme or antigen, Component B: an antibody against the antigen of component A, and Component C: a substrate for the enzyme of the component A.
Claim 19
Dependent Claim 18 words
The kit according to claim 15, wherein the Component A is an enzyme-labeled antigen of the formula: ##STR19##
Claim 20
Dependent Claim 97 words
A process for preparing an enzyme-labeled antigen suitable for an enzyme immuno assay having the following formula: ##STR20## wherein X and Y are different and are each an enzyme or antigen, which comprises reacting a compound of the formula: ##STR21## with an antigen or enzyme containing an amino group but having no thiol group under conditions which produce a bound product of the formula: ##STR22## wherein X is the same as defined above, and reacting the resulting bound product (III) with an enzyme or antigen containing a thiol group under conditions which produce the enzyme labeled antigen.
Claim 21
Dependent Claim 97 words
A process for preparing an enzyme-labeled antigen suitable for an enzyme immuno assay having the following formula: ##STR20## wherein X and Y are different and are each an enzyme or antigen, which comprises reacting a compound of the formula: ##STR21## with an antigen or enzyme containing an amino group but having no thiol group under conditions which produce a bound product of the formula: ##STR22## wherein X is the same as defined above, and reacting the resulting bound product (III) with an enzyme or antigen containing a thiol group under conditions which produce the enzyme labeled antigen.
Claim 22
Dependent Claim 39 words
The process according to claim 17, wherein the compound (I) is reacted with an antigen containing an amino group but containing no thiol group, and the resulting bound product (III) is reacted with an enzyme containing a thiol group.

References Cited (Backward Citations)

US3770820A Cited
US3887582A Cited
US3852157A Cited
US3875011A Cited
US3969287A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-07-22 1984-01-21 1984-07-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-07-22 1988-01-21 1988-07-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-07-22 1992-01-21 1992-07-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag